BACKGROUND/AIMS: The aim of this study was to evaluate the impact of diabetes mellitus (DM) on in-hospital and 1-year mortality in patients who suffered acute myocardial infarction (AMI) and underwent successful percutaneous coronary intervention (PCI). METHODS: Among 5,074 consecutive patients from the Korea AMI Registry with successful revascularization between November 2005 and June 2007, 1,412 patients had a history of DM. RESULTS: The DM group had a higher mean age prevalence of history of hypertension, dyslipidemia, ischemic heart disease, high Killip class, and diagnoses as non-ST elevation MI than the non-DM group. Left ventricular ejection fraction (LVEF) and creatinine clearance were lower in the DM group, which also had a significantly higher incidence of in-hospital and 1-year mortality of hospital survivors (4.6% vs. 2.8%, p = 0.002; 5.0% vs. 2.5%, p < 0.001). A multivariate analysis revealed that independent predictors of in-hospital mortality were Killip class IV or III at admission, use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, LVEF, creatinine clearance, and a diagnosis of ST-elevated MI but not DM. However, a multivariate Cox regression analysis showed that DM was an independent predictor of 1-year mortality (hazard ratio, 1.504; 95% confidence interval, 1.032 to 2.191). CONCLUSIONS: DM has a higher association with 1-year mortality than in-hospital mortality in patients with AMI who underwent successful PCI. Therefore, even when patients with AMI and DM undergo successful PCI, they may require further intensive treatment and continuous attention.
BACKGROUND/AIMS: The aim of this study was to evaluate the impact of diabetes mellitus (DM) on in-hospital and 1-year mortality in patients who suffered acute myocardial infarction (AMI) and underwent successful percutaneous coronary intervention (PCI). METHODS: Among 5,074 consecutive patients from the Korea AMI Registry with successful revascularization between November 2005 and June 2007, 1,412 patients had a history of DM. RESULTS: The DM group had a higher mean age prevalence of history of hypertension, dyslipidemia, ischemic heart disease, high Killip class, and diagnoses as non-ST elevation MI than the non-DM group. Left ventricular ejection fraction (LVEF) and creatinine clearance were lower in the DM group, which also had a significantly higher incidence of in-hospital and 1-year mortality of hospital survivors (4.6% vs. 2.8%, p = 0.002; 5.0% vs. 2.5%, p < 0.001). A multivariate analysis revealed that independent predictors of in-hospital mortality were Killip class IV or III at admission, use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, LVEF, creatinine clearance, and a diagnosis of ST-elevated MI but not DM. However, a multivariate Cox regression analysis showed that DM was an independent predictor of 1-year mortality (hazard ratio, 1.504; 95% confidence interval, 1.032 to 2.191). CONCLUSIONS:DM has a higher association with 1-year mortality than in-hospital mortality in patients with AMI who underwent successful PCI. Therefore, even when patients with AMI and DM undergo successful PCI, they may require further intensive treatment and continuous attention.
Authors: D Hasdai; C B Granger; S S Srivatsa; D A Criger; S G Ellis; R M Califf; E J Topol; D R Holmes Journal: J Am Coll Cardiol Date: 2000-05 Impact factor: 24.094
Authors: Nick E J West; Peter N Ruygrok; Clemens M C Disco; Mark W I Webster; Wietze K Lindeboom; William W O'Neill; Nestor F Mercado; Patrick W Serruys Journal: Circulation Date: 2004-02-02 Impact factor: 29.690
Authors: Peter W Radke; Marc Voswinkel; Matthias Reith; Axel Kaiser; Philipp K Haager; Peter Hanrath; Rainer Hoffmann Journal: Am J Cardiol Date: 2004-03-01 Impact factor: 2.778
Authors: PierMarco Piatti; Carlo Di Mario; Lucilla D Monti; Gabriele Fragasso; Fabio Sgura; Andrea Caumo; Emanuela Setola; Pietro Lucotti; Elena Galluccio; Cristina Ronchi; Anna Origgi; Ivana Zavaroni; Alberto Margonato; Antonio Colombo Journal: Circulation Date: 2003-10-06 Impact factor: 29.690
Authors: Young Joon Hong; Myung Ho Jeong; Ok Young Park; Weon Kim; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Byoung Hee Ahn; Soon Pal Suh; Jong Chun Park; Sang Hyung Kim; Jung Chaee Kang Journal: Korean J Intern Med Date: 2003-03 Impact factor: 2.884
Authors: Hyun Kuk Kim; Myung Ho Jeong; Seung Hun Lee; Doo Sun Sim; Young Joon Hong; Youngkeun Ahn; Chong Jin Kim; Myeong Chan Cho; Young Jo Kim Journal: Korean J Intern Med Date: 2014-10-31 Impact factor: 2.884
Authors: Pil Sang Song; Dong Ryeol Ryu; Min Jeong Kim; Ki Hyun Jeon; Rak Kyeong Choi; Jin Sik Park; Young Bin Song; Joo Yong Hahn; Hyeon Cheol Gwon; Youngkeun Ahn; Myung Ho Jeong; Seung Hyuk Choi Journal: Korean Circ J Date: 2018-06 Impact factor: 3.243
Authors: Hyun Woong Park; Min Gyu Kang; Kyehwan Kim; Jin Sin Koh; Jeong Rang Park; Young Hoon Jeong; Jong Hwa Ahn; Jeong Yoon Jang; Choong Hwan Kwak; Yongwhi Park; Myung Ho Jeong; Young Jo Kim; Myeong Chan Cho; Chong Jin Kim; Jin Yong Hwang Journal: Korean Circ J Date: 2018-02 Impact factor: 3.243